Current Psychiatry Research and Reviews
Title:Rethinking Depression
Volume: 15 Issue: 1
Author(s): Yong-Ku Kim
Affiliation:
Export Options
About this article
Cite this article as:
Kim Yong-Ku , Rethinking Depression, Current Psychiatry Research and Reviews 2019; 15 (1) . https://dx.doi.org/10.2174/266608221501190416112800
DOI https://dx.doi.org/10.2174/266608221501190416112800 |
Print ISSN 2666-0822 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-0830 |
21
2
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Review of Current Chemoinformatic Tools for Modeling Important Aspects of CYPsmediated Drug Metabolism. Integrating Metabolism Data with Other Biological Profiles to Enhance Drug Discovery
Current Drug Metabolism Advancements in the Understanding of Paclitaxel Metabolism in Tissue Culture
Current Pharmaceutical Biotechnology Scutellaria barbata Flavonoids Improve the Composited Aβ-induced Abnormal Changes in Glial Cells of the Brains of Rats
Combinatorial Chemistry & High Throughput Screening Antioxidant and Antiinflammatory Activities of Curcumin on Diabetes Mellitus and its Complications
Current Pharmaceutical Design microRNAs in Autism Spectrum Disorders
Current Pharmaceutical Design Cyclooxygenases Regulation by Estradiol on Endothelium
Current Pharmaceutical Design Blockade of Phosphodiesterase-III Protects Against Oxygen-Glucose Deprivation in Endothelial Cells by Upregulation of VE-Cadherin
Current Neurovascular Research Sialic Acid Recognition of the Pandemic Influenza 2009 H1N1 Virus: Binding Mechanism Between Human Receptor and Influenza Hemagglutinin
Protein & Peptide Letters Message from the Editor-in-Chief
CNS & Neurological Disorders - Drug Targets NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Current Pharmaceutical Design Gonadal Hormones in Adolescent Females with β-Thalassemia in Relation to Iron Load
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Neurogenesis and Angiogenesis in Depression
Current Neurovascular Research RAGE and RAGE Ligands in Cancer
Current Molecular Medicine Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Anti-Cancer Agents in Medicinal Chemistry Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
Current Medicinal Chemistry Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials
Current Drug Targets Glyceraldehyde-3-phosphate Dehydrogenase from Chironomidae Showed Differential Activity Towards Metals
Protein & Peptide Letters The Effect of Tele-acupressure Self-practice for Mental Health and Wellbeing in the Community During COVID-19
Current Psychiatry Research and Reviews A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry